Format

Send to

Choose Destination
Proteomics Clin Appl. 2015 Apr;9(3-4):322-34. doi: 10.1002/prca.201400115. Epub 2015 Mar 24.

CE-MS-based proteomics in biomarker discovery and clinical application.

Author information

1
Department of R&D, Mosaiques Diagnostics GmbH, Hanover, Germany; Charité-Universitätsmedizin Berlin, Berlin, Germany.

Abstract

CE-MS is applied in clinical proteomics for both the identification of biomarkers of disease and assessment of biomarkers in clinical diagnosis. The analysis is reproducible, fast, and requires only small sample volumes. However, successful CE-MS analysis depends on several critical steps that can be consolidated as follows: (i) proper sample preparation and fractionation, (ii) application of suitable capillary coating and appropriate CE-MS interfaces, to ensure the reproducibility and stability of the analysis, and (iii) an optimized clinical and statistical study design to increase the chances for obtaining clinically relevant results. In this review, we cover all these aspects, and present several examples of the application of CE-MS in clinical proteomics.

KEYWORDS:

Biomarker; Capillary electrophoresis; Clinical proteomics; Mass spectrometry; Peptidomics

PMID:
25641774
DOI:
10.1002/prca.201400115
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center